Literature DB >> 24305929

In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy.

Kazunari Sasaki1, Masamichi Matsuda, Yu Ohkura, Yusuke Kawamura, Masafumi Inoue, Masaji Hashimoto, Kenji Ikeda, Hiromitsu Kumada, Goro Watanabe.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) often consists of various differentiation components in a single tumor. However, the categorization of histologic grade in hepatectomy for those tumors has not been standardized. Some studies have determined the differentiation grade of the tumor according to its worst component, whereas others have determined it according to its predominant component. The present study aimed to resolve the controversy about whether the worst component or the dominant component determines the nature of the tumor, especially focusing on the presence of a poorly differentiated component (PDC).
METHODS: In total, 427 hepatectomized patients with solitary HCC were divided into three groups, tumors without a PDC (NP), tumors with a PDC but dominantly consisting of non-PDC as poorly contained (PC), and tumors predominantly consisted of a PDC as poorly dominant (PD). PC was compared with PD and NP.
RESULTS: Statistical analysis revealed that large tumors and high alpha-fetoprotein level were significantly more frequent in PC than in NP (P < 0.01 and P = 0.04, respectively), although no remarkable difference was observed between PC and PD. Both recurrence-free and overall survival rates were significantly worse in the PC and PD groups than in the NP group (PC vs. NP: P = 0.01 and P < 0.01, PD vs. NP: P < 0.01 and P < 0.01, respectively), but there was no significant difference in these parameters between PC and PD.
CONCLUSIONS: All HCC, including PDC, should be categorized as poorly differentiated HCC regardless of the predominant differentiation component.

Entities:  

Mesh:

Year:  2014        PMID: 24305929     DOI: 10.1007/s00268-013-2374-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation.

Authors:  Dai Hoon Han; Gi Hong Choi; Kyung Sik Kim; Jin Sub Choi; Young Nyun Park; Seung Up Kim; Jun Yong Park; Sang Hoon Ahn; Kwang-Hyub Han
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

2.  Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC.

Authors:  K Kenmochi; S Sugihara; M Kojiro
Journal:  Liver       Date:  1987-02

3.  Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

Authors:  S Tamura; T Kato; M Berho; E P Misiakos; C O'Brien; K R Reddy; J R Nery; G W Burke; E R Schiff; J Miller; A G Tzakis
Journal:  Arch Surg       Date:  2001-01

4.  DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinoma.

Authors:  Xiao-Hong Shi; Yan Zheng; Qing Sun; Jing Cui; Qing-Hua Liu; Fei Qü; Yun-Shan Wang
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

5.  Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy.

Authors:  Katsunori Imai; Toru Beppu; Yoshiharu Nakayama; Takatoshi Ishiko; Kei Horino; Hiroyuki Komori; Toshiro Masuda; Hiromitsu Hayashi; Hirohisa Okabe; Yoshihumi Baba; Masayuki Watanabe; Hiroshi Takamori; Kazuo Awai; Yasuyuki Yamashita; Hideo Baba
Journal:  J Surg Oncol       Date:  2009-08-01       Impact factor: 3.454

6.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.

Authors:  K Ikeda; S Saitoh; A Tsubota; Y Arase; K Chayama; H Kumada; G Watanabe; M Tsurumaru
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

7.  Histological grading of colorectal cancer: a simple and objective method.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Megumi Ishiguro; Yoshiki Kajiwara; Taichi Sato; Hideyuki Shimazaki; Kazuo Hase; Ian C Talbot
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

8.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

Review 9.  Surgical management of hepatocellular carcinoma: is the jury still out?

Authors:  G Morris-Stiff; D Gomez; N de Liguori Carino; K R Prasad
Journal:  Surg Oncol       Date:  2008-12-05       Impact factor: 3.279

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  13 in total

1.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

2.  Convolutional neural network for classifying primary liver cancer based on triple-phase CT and tumor marker information: a pilot study.

Authors:  Hirotsugu Nakai; Koji Fujimoto; Rikiya Yamashita; Toshiyuki Sato; Yuko Someya; Kojiro Taura; Hiroyoshi Isoda; Yuji Nakamoto
Journal:  Jpn J Radiol       Date:  2021-03-10       Impact factor: 2.374

3.  Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter.

Authors:  Jia Ding; Xiao-Tian Zhou; Hao-Yu Zou; Jian Wu
Journal:  Lab Invest       Date:  2017-04-17       Impact factor: 5.662

4.  Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells.

Authors:  Y-H Fan; J Ding; S Nguyen; X-J Liu; G Xu; H-Y Zhou; N-N Duan; S-M Yang; M A Zern; J Wu
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

5.  Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.

Authors:  Yanfang Zhang; Xuezhong Lei; Liangliang Xu; Xiaoju Lv; Mingqing Xu; Hong Tang
Journal:  BMC Surg       Date:  2022-06-17       Impact factor: 2.030

6.  Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.

Authors:  Jung-Woo Lee; Young-Joo Lee; Kwang-Min Park; Dae-Wook Hwang; Jae Hoon Lee; Ki Byung Song
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

7.  Diagnosis system for hepatocellular carcinoma based on fractal dimension of morphometric elements integrated in an artificial neural network.

Authors:  Dan Ionuț Gheonea; Costin Teodor Streba; Cristin Constantin Vere; Mircea Şerbănescu; Daniel Pirici; Maria Comănescu; Letiția Adela Maria Streba; Marius Eugen Ciurea; Stelian Mogoantă; Ion Rogoveanu
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

8.  Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).

Authors:  Chaohui Zuo; Man Xia; Qunfeng Wu; Haizhen Zhu; Jingshi Liu; Chen Liu
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

9.  Diagnostic Value of Imaging Methods in the Histological Four Grading of Hepatocellular Carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masayuki Nakano; Mikiko Tanabe; Makoto Chuma; Hiromi Nihonmatsu; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masahiro Okada; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2020-05-19

10.  Histological Grading of Hepatocellular Carcinoma-A Systematic Review of Literature.

Authors:  Sebastiao N Martins-Filho; Caterina Paiva; Raymundo Soares Azevedo; Venancio Avancini Ferreira Alves
Journal:  Front Med (Lausanne)       Date:  2017-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.